Published in J Clin Pathol on August 01, 1990
Nucleolar organiser regions in pathology. Br J Cancer (1992) 1.12
Diagnostic importance of AgNOR pleomorphism in cervical carcinogenesis. Ecancermedicalscience (2013) 0.82
Nucleolar organiser regions (AgNORS) in anal intraepithelial neoplasia and invasive anal squamous cell carcinoma. J Clin Pathol (1992) 0.78
Endocervical carcinoma and precursor lesions: c-myc expression and the demonstration of field changes. J Clin Pathol (1991) 0.78
Nucleolar organizer regions in lymphomas. J Pathol (1987) 4.46
Nucleolar organiser region associated proteins in cutaneous melanotic lesions: a quantitative study. J Clin Pathol (1987) 3.23
Evaluation of nucleolar organizer region-associated proteins in breast malignancy. Histopathology (1988) 2.40
Silver-binding nucleolar organizer regions (AgNORs) in benign and malignant breast lesions: correlations with ploidy and growth phase by DNA flow cytometry. J Pathol (1989) 1.51
Predictive value of cone margins and post-cone endocervical curettage with residual disease in subsequent hysterectomy. Gynecol Oncol (1989) 1.20
Glandular lesions of the uterine cervix: the present state of our knowledge. Histopathology (1986) 1.13
Adenocarcinoma in situ of the cervix: an underdiagnosed lesion. Cancer (1981) 0.98
Cervical adenocarcinoma and oral contraceptives. Br Med J (Clin Res Ed) (1987) 0.94
Noninvasive precursor lesions of adenocarcinoma and mixed adenosquamous carcinoma of the cervix uteri. Cancer (1979) 0.91
Cytoplasmic reactivity with the monoclonal antibody HMFG1 as a marker of cervical glandular atypia. J Pathol (1987) 0.91
Intermediate filaments in endometrial and endocervical carcinomas. The diagnostic utility of vimentin patterns. Am J Surg Pathol (1986) 0.89
In-situ and microinvasive adenocarcinoma of the uterine cervix. A clinical, cytologic and histologic study of 14 cases. Am J Clin Pathol (1975) 0.87
Early stage adenocarcinoma of the uterine cervix. Histopathologic analysis with consideration of histogenesis. Cancer (1985) 0.86
Invasive adenocarcinoma of the uterine cervix. Obstet Gynecol (1977) 0.85
Increased incidence of adenocarcinoma of uterine cervix. Obstet Gynecol (1975) 0.84
Microinvasive carcinoma in gynaecological pathology. Clin Obstet Gynaecol (1984) 0.83
Expression of epithelial membrane and 3-fucosyl-N-acetyllactosamine antigens in cervix uteri with particular reference to adenocarcinoma in situ. J Clin Pathol (1988) 0.81
Early endocervical glandular neoplasia. II. Morphometric analysis of the cells. Acta Cytol (1986) 0.80
Increase of cervical adenocarcinoma: a report of 520 cases of cervical carcinoma including 112 tumors with glandular elements. Gynecol Oncol (1989) 0.80
FOLLOW-UP OF PATIENTS WITH ADENOCARCINOMA OF THE CERVIX AND CERVICAL STUMP. Am J Obstet Gynecol (1965) 0.80
Nucleolar organiser regions and proliferative index in glandular and squamous carcinomas of the cervix. J Clin Pathol (1989) 0.79
Adenocarcinoma of the uterine cervix: a study of 73 cases. Obstet Gynecol (1985) 0.79
SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science (1991) 12.93
Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med (1998) 7.60
Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen (2000) 6.24
RANK is essential for osteoclast and lymph node development. Genes Dev (1999) 5.85
Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J (1994) 5.69
Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med (1994) 5.20
A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science (1990) 4.90
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med (1996) 4.70
The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms. Cell (1989) 4.48
Src homology region 2 domains direct protein-protein interactions in signal transduction. Proc Natl Acad Sci U S A (1990) 4.13
Management of women with mild and moderate cervical dyskaryosis. BMJ (1994) 3.65
Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nat Genet (1996) 3.56
Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. J Exp Med (1992) 3.34
A small viral RNA is required for in vitro packaging of bacteriophage phi 29 DNA. Science (1987) 3.29
Congenital rubella syndrome: a risk in immigrant populations. Lancet (2002) 3.08
Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles. Cell (1990) 2.95
CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell (1993) 2.73
Prohead and DNA-gp3-dependent ATPase activity of the DNA packaging protein gp16 of bacteriophage phi 29. J Mol Biol (1987) 2.59
Risk factors for surgical site infection following caesarean section in England: results from a multicentre cohort study. BJOG (2012) 2.57
Retained surgical swabs in 13 dogs. Vet Rec (2011) 2.54
Cloning determinants of pathogenesis from Pseudomonas syringae pathovar syringae. Proc Natl Acad Sci U S A (1985) 2.50
Enhancement of recovery from psychiatric illness by methylfolate. Br J Psychiatry (1992) 2.44
The DNA sequence and biological annotation of human chromosome 1. Nature (2006) 2.42
Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am J Hum Genet (1999) 2.35
Recombinant interleukin 7, pre-B cell growth factor, has costimulatory activity on purified mature T cells. J Exp Med (1989) 2.30
Managing oral anticoagulant therapy. Chest (2001) 2.25
IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. International Programme on Chemical Safety. Mutat Res (2000) 2.14
Function of hexameric RNA in packaging of bacteriophage phi 29 DNA in vitro. Mol Cell (1998) 2.13
A defined system for in vitro packaging of DNA-gp3 of the Bacillus subtilis bacteriophage phi 29. Proc Natl Acad Sci U S A (1986) 2.07
Antitumour activity of docetaxel following treatment with the CYP17A1 inhibitor abiraterone: clinical evidence for cross-resistance? Ann Oncol (2012) 2.07
Graduated compression stockings to treat acute leg pain associated with proximal DVT. A randomised controlled trial. Thromb Haemost (2014) 2.02
Evaluation of six short term tests for detecting organic chemical carcinogens and recommendations for their use. Nature (1976) 2.00
SH2 domains of the p85 alpha subunit of phosphatidylinositol 3-kinase regulate binding to growth factor receptors. Mol Cell Biol (1992) 2.00
Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res (1996) 1.95
The N-terminal region of GAP regulates cytoskeletal structure and cell adhesion. EMBO J (1993) 1.91
Hepatitis E virus infection among animals in northern India: an unlikely source of human disease. J Viral Hepat (2007) 1.85
On-demand single-electron transfer between distant quantum dots. Nature (2011) 1.75
Selection of temperature-sensitive activating enzyme mutants in Escherichia coli. J Bacteriol (1968) 1.75
Thymidine kinase obliteration: creation of transgenic mice with controlled immune deficiency. Proc Natl Acad Sci U S A (1989) 1.74
Multigene DNA priming-boosting vaccines protect macaques from acute CD4+-T-cell depletion after simian-human immunodeficiency virus SHIV89.6P mucosal challenge. J Virol (2003) 1.70
Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma. Cochrane Database Syst Rev (2003) 1.70
Prevalence of mental retardation and developmental disabilities: estimates from the 1994/1995 National Health Interview Survey Disability Supplements. Am J Ment Retard (2001) 1.70
Regulation of the phage phi 29 prohead shape and size by the portal vertex. Virology (1991) 1.70
A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family. Hum Mol Genet (2001) 1.70
Cerebral fungal infections in the immunocompromised host: a literature review and a new pathogen--Chaetomium atrobrunneum: case report. Neurosurgery (1998) 1.69
Cloning, sequence, and expression of a human granulocyte/macrophage colony-stimulating factor. Proc Natl Acad Sci U S A (1985) 1.62
Therapeutic plasma exchange: an update from the Canadian Apheresis Group. Ann Intern Med (1999) 1.61
Characterization of the prohead-pRNA interaction of bacteriophage phi 29. J Biol Chem (1994) 1.58
Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non-polyposis colorectal cancer: identification of novel and recurrent deletions by MLPA. Hum Mutat (2003) 1.57
Pituitary tumors and the ophthalmologist. Ophthalmology (1983) 1.55
Characterization of the small RNA of the bacteriophage phi 29 DNA packaging machine. Nucleic Acids Res (1987) 1.53
A prospective study of lung water measurements during patient management in an intensive care unit. Am Rev Respir Dis (1987) 1.52
Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FC gamma RIII. Biotechnol Bioeng (2001) 1.52
Clindamycin treatment of osteomyelitis and septic arthritis in children. Pediatrics (1975) 1.49
Is there ever a role for salvage operations in limited small-cell lung cancer? J Thorac Cardiovasc Surg (1991) 1.46
Mild growth retardation and developmental delay, microcephaly, and a distinctive facial appearance. Am J Med Genet (1994) 1.46
Trends among pathogens reported as causing bacteraemia in England, 2004-2008. Clin Microbiol Infect (2011) 1.44
An evaluation of 6 short-term tests for detecting organic chemical carcinogens. Br J Cancer (1978) 1.44
Cooperative binding of Agrobacterium tumefaciens VirE2 protein to single-stranded DNA. J Bacteriol (1989) 1.44
Hemostasis and cold knife cone biopsy: a prospective randomized trial comparing a suture versus non-suture technique. Obstet Gynecol (1989) 1.44
Heterogeneity in human interleukin-3 receptors. A subclass that binds human granulocyte/macrophage colony stimulating factor. J Biol Chem (1989) 1.44
Metastasis-induced acute pancreatitis in small cell bronchogenic carcinoma. Arch Intern Med (1979) 1.44
Mouse nerve growth factor gene: structure and expression. Mol Cell Biol (1987) 1.43
Function-sparing surgery for desmoid tumors and other low-grade fibrosarcomas involving the brachial plexus. Neurosurgery (1998) 1.42
Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol (1989) 1.42
Diagnosis of fetal submicroscopic chromosomal abnormalities in failed array CGH samples: copy number by sequencing as an alternative to microarrays for invasive fetal testing. Ultrasound Obstet Gynecol (2015) 1.41
The bacteriophage phi29 packaging proteins supercoil the DNA ends. J Mol Biol (1997) 1.40
Melittin forms crystals which are suitable for high resolution X-ray structural analysis and which reveal a molecular 2-fold axis of symmetry. J Biol Chem (1980) 1.40
Aid for Medical Adventurers. Can Med Assoc J (1965) 1.39
Ciprofloxacin does not block the antiproliferative effect of tacrolimus. Transplantation (1997) 1.39
Hes6 acts in a positive feedback loop with the neurogenins to promote neuronal differentiation. Development (2000) 1.38
Appeal against detention under the Mental Health Act 1983: relationship to age and incapacity. Int J Geriatr Psychiatry (2002) 1.38
Depression and suicidal ideation in African-American and Hispanic American high school students. Psychol Rep (1992) 1.38
Long-term methicillin-resistant Staphylococcus aureus (MRSA) carriage and tagging of patient records. J Hosp Infect (1997) 1.38
Effect of murine mast cell growth factor (c-kit proto-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells. Blood (1991) 1.35
RNA dependence of the bacteriophage phi 29 DNA packaging ATPase. J Mol Biol (1990) 1.34
Analysis of genetic and phenotypic heterogeneity in juvenile polyposis. Gut (2000) 1.34
Pre-ejaculatory fluid as potential vector for sexual transmission of HIV-1. Lancet (1992) 1.32
Induction of chimerism in rhesus macaques through stem cell transplant and costimulation blockade-based immunosuppression. Am J Transplant (2007) 1.30
A pilot study of the benefit of colposcopy as a further screening procedure within the community health service. Community Med (1986) 1.30
Human leptospirosis from immunized dogs. Ann Intern Med (1973) 1.29
Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. Cancer Res (1983) 1.29
Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype. J Clin Invest (2000) 1.29
The effects of male age on sperm DNA damage in healthy non-smokers. Hum Reprod (2006) 1.27
Anal intraepithelial neoplasia: part of a multifocal disease process. Lancet (1992) 1.27
Multiple SH2-mediated interactions in v-src-transformed cells. Mol Cell Biol (1992) 1.27
Mutations in DPC4 (SMAD4) cause juvenile polyposis syndrome, but only account for a minority of cases. Hum Mol Genet (1998) 1.26
Orchitis and human immunodeficiency virus type 1 infected cells in reproductive tissues from men with the acquired immune deficiency syndrome. Am J Pathol (1991) 1.26
Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation. Lancet (1993) 1.24
Sensitivity and specificity of a rapid whole-blood assay for D-dimer in the diagnosis of pulmonary embolism. Ann Intern Med (1998) 1.24
Elimination of Fc receptor-dependent effector functions of a modified IgG4 monoclonal antibody to human CD4. J Immunol (2000) 1.23
Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update. N Engl J Med (1987) 1.23
Initiation events in in-vitro packaging of bacteriophage phi 29 DNA-gp3. J Mol Biol (1987) 1.23
In vivo rodent erythrocyte micronucleus assay. Mutat Res (1994) 1.22
The association of insulin-elicited phosphotyrosine proteins with src homology 2 domains. J Biol Chem (1992) 1.22
Safety and peri-operative medical care. Anaesthesia (2001) 1.21
Outcome after surgical resection for high-grade anal intraepithelial neoplasia (Bowen's disease). Br J Surg (1999) 1.21